NCT01142050 - Stem Cell Therapy for Type 2 Diabetes Mellitus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

December 31, 2011

Conditions

Type 2 Diabetes Mellitus

Interventions

BIOLOGICAL

mesenchymal stem cells

1.1st transplantation: after finishing all required examines according to protocol in Day 0, ABM-MSCs are transplanted through pancreas artery percutaneously; 2. 2nd transplantation: after finishing all required examines in Day 7±1, BM-MSCs are transplanted intravenously; 3. 3rd transplantation: after finishing all required examines in Day 14±2, BM-MSCs are transplanted intravenously.

Trial Locations (1)

100085

Armed Police General Hospital, P.R. China, Beijing